Kidney Injury Molecule‐1 (KIM‐1): A specific and sensitive biomarker of kidney injury

References

• Levey A. S., Coresh J., Balk E., Kausz A. T., Levin A., Steffes M. W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–47
   PubMed Web of Science ®Google Scholar
• Ichimura T., Bonventre J. V., Bailly V., Wei H., Hession C. A., Cate R. L., et al. Kidney injury molecule‐1 (KIM‐1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up‐regulated in renal cells after injury. J Biol Chem 1998; 273: 4135–42
   PubMed Web of Science ®Google Scholar
• Hubank M., Schatz D. G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucl Acid Res 1994; 22: 5640–8
   PubMed Web of Science ®Google Scholar
• Bailly V., Zhang Z., Meier W., Cate R., Sanicola M., Bonventre J. V. Shedding of kidney injury molecule‐1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002; 277: 39739–48
   PubMed Web of Science ®Google Scholar
• Amin R. P., Vickers A. E., Sistare F., Thompson K. L., Roman R. J., Lawton M., et al. Identification of putative gene based markers of renal toxicity. Environ Health Perspect 2004; 112: 465–79
   PubMed Web of Science ®Google Scholar
• McIntire J. J., Umetsu S. E., Akbari O., Potter M., Kuchroo V. K., Barsh G. S., et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001; 2: 1109–16
   PubMed Web of Science ®Google Scholar
• Umetsu S. E., Lee W. L., McIntire J. J., Downey L., Sanjanwala B., Akbari O., et al. TIM‐1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005; 6: 447–54
   PubMed Web of Science ®Google Scholar
• Kuchroo V. K., Meyers J. H., Umetsu D. T., DeKruyff R. H. TIM family of genes in immunity and tolerance. Adv Immunol 2006; 91: 227–49
   PubMed Web of Science ®Google Scholar
• Meyers J. H., Sabatos C. A., Chakravarti S., Kuchroo V. K. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med 2005; 11: 362–9
   PubMed Web of Science ®Google Scholar
• Ichimura T., Hung C. C., Yang S. A., Stevens J. L., Bonventre J. V. Kidney injury molecule‐1: a tissue and urinary biomarker for nephrotoxicant‐induced renal injury. Am J Physiol Renal Physiol 2004; 286: F552–63
   PubMed Web of Science ®Google Scholar
• Espandiari P., Zhang J., Rosenzweig B. A., Vaidya V. S., Sun J., Schnackenberg L., et al. The utility of a rodent model in detecting pediatric drug‐induced nephrotoxicity. Toxicol Sci 2007; 99: 637–48
   PubMed Web of Science ®Google Scholar
• Zhou Y., Vaidya V. S., Brown R. P., Zhang J., Rosenzweig B. A., Thompson K. L., et al. Comparison of kidney injury molecule‐1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci 2008; 101: 159–70
   PubMed Web of Science ®Google Scholar
• Prozialeck W. C., Vaidya V. S., Liu J., Waalkes M. P., Edwards J. R., Lamar P. C., et al. Kidney injury molecule‐1 is an early biomarker of cadmium nephrotoxicity. Kidney Int 2007; 72: 985–93
   PubMed Web of Science ®Google Scholar
• Vaidya V. S., Ramirez V., Ichimura T., Bobadilla N. A., Bonventre J. V. Urinary kidney injury molecule‐1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006; 290: F517–29
   PubMed Web of Science ®Google Scholar
• Han W. K., Bailly V., Abichandani R., Thadhani R., Bonventre J. V. Kidney injury molecule‐1 (KIM‐1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237–44
   PubMed Web of Science ®Google Scholar
• Zhang Z., Humphreys B. D., Bonventre J. V. Shedding of the urinary biomarker kidney injury molecule‐1 (KIM‐1) is regulated by MAP kinases and juxtamembrane region. J Am Soc Nephrol 2007; 18: 2704–14
   PubMed Web of Science ®Google Scholar
• Vaidya V. S., Bonventre J. V. Mechanistic biomarkers for cytotoxic acute kidney injury. Expert Opin Drug Metab Toxicol 2006; 2: 697–713
   PubMed Web of Science ®Google Scholar
• Thukral S. K., Nordone P. J., Hu R., Sullivan L., Galambos E., Fitzpatrick V. D., et al. Prediction of nephrotoxicant action and identification of candidate toxicity‐related biomarkers. Toxicol Pathol 2005; 33: 343–55
   PubMed Web of Science ®Google Scholar
• Rached E., Hoffmann D., Blumbach K., Weber K., Dekant W., Mally A. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin A in vivo and in vitro. Toxicol Sci 2008
   PubMed Web of Science ®Google Scholar
• van Timmeren M. M., Bakker S. J., Vaidya V. S., Bailly V., Schuurs T. A., Damman J., et al. Tubular kidney injury molecule‐1 in protein‐overload nephropathy. Am J Physiol Renal Physiol 2006; 291: F456–64
   PubMed Web of Science ®Google Scholar
• Kramer A. B., van der Meulen E. F., Hamming I., van Goor H., Navis G. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kidney Int 2007; 71: 417–24
   PubMed Web of Science ®Google Scholar
• Tsuji M., Monkawa T., Yoshino J., Asai M., Fukuda S., Kawachi H., et al. Microarray analysis of a reversible model and an irreversible model of anti‐Thy‐1 nephritis. Kidney Int 2006; 69: 996–1004
   PubMed Web of Science ®Google Scholar
• Schuurs T. A., Gerbens F., van der Hoeven J. A., Ottens P. J., Kooi K. A., Leuvenink H. G., et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant 2004; 4: 1972–81
   PubMed Web of Science ®Google Scholar
• Perez‐Rojas J., Blanco J. A., Cruz C., Trujillo J., Vaidya V. S., Uribe N., et al. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 2007; 292: F131–9
   PubMed Web of Science ®Google Scholar
• Hong M. E., Hong J. C., Stepkowski S., Kahan B. D. Correlation between cyclosporine‐induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule‐1 and aquaporin‐2 gene. Transplant Proc 2005; 37: 4254–8
   PubMed Web of Science ®Google Scholar
• Mukherjea D., Whitworth C. A., Nandish S., Dunaway G. A., Rybak L. P., Ramkumar V. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin. Neuroscience 2006; 139: 733–40
   PubMed Web of Science ®Google Scholar
• Liangos O., Perianayagam M. C., Vaidya V. S., Han W. K., Wald R., Tighiouart H., et al. Urinary N‐acetyl‐{beta}‐(D)‐glucosaminidase activity and Kidney Injury Molecule‐1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007
   Web of Science ®Google Scholar
• Zhang P. L., Rothblum L. I., Han W. K., Blasick T. M., Potdar S., Bonventre J. V. Kidney injury molecule‐1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int 2008; 73: 608–14
   PubMed Web of Science ®Google Scholar
• van Timmeren M. M., Vaidya V. S., van Ree R. M., Oterdoom L. H., de Vries A. P., Gans R. O., et al. High urinary excretion of kidney injury molecule‐1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007; 84: 1625–30
   PubMed Web of Science ®Google Scholar
• Han W. K., Alinani A., Wu C. L., Michaelson D., Loda M., McGovern F. J., et al. Human kidney injury molecule‐1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol 2005; 16: 1126–34
   PubMed Web of Science ®Google Scholar
• Kuehn E. W., Park K. M., Somlo S., Bonventre J. V. Kidney injury molecule‐1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol 2002; 283: F1326–36
   PubMed Web of Science ®Google Scholar